30303 people have viewed this drug in the last 60 days
Updated 2025-10-03
| Last Update | 2022-08-31 |
| Register Year | 2016 |
| Product Type | Human |
| Drug Type | Biological |
| Scientific Name | RANIBIZUMAB |
| Trade Name | LUCENTIS 10MG-ML INTRAVITREAL Injection |
| Strength Unit | mg/ml |
| Pharmaceutical Form | Solution for injection |
| Administration Route | Intravenous use |
| Atc Code1 | S01LA04 |
| Atc Code2 | |
| Size | 1 |
| Size Unit | |
| Package Types | Vial |
| Package Size | 1 |
| Legal Status | Prescription |
| Product Control | Uncontrolled |
| Distribute Area | Hospital |
| Public price | $2942.4 |
| Shelf Life | 36 Months |
| Marketing Company | NOVARTIS PHARMA AG |
| Marketing Country | Switzerland |
| Manufacture Name | NOVARTIS Pharma Stein AG |
| Manufacture Country | Switzerland |
| Secondry package manufacture | |
| Main Agent | Novartis Saudi Limited |
| Secosnd Agent | |
| Third Agent | |
| Visits | 30303 |
Do not forget, after purchasing the medicine, help us determine the price more accurately, press the button below and adjust the price directly
| Name | Price | Visits | Updated |
|---|---|---|---|
| LUCENTIS 10MG-ML INTRAVITREAL Injection | $2942.4 | 30303 visits | 2022-08-31 |